Skip to main content

S. Muoio & Co. LLC

SEC CIK
0001138996
Latest filing
Nov 14, 2022

The latest 13F from S. Muoio & Co. LLC covers Q3 2022 (filed Nov 14, 2022): 62 long positions worth $75.7M. The top 10 holdings make up 42.0% of the portfolio, and the largest is Nexstar Media Group, Inc. (NXST) at 6.2%. Livermore has 7 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q3 2022

Share counts compared with Q2 2022: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
21
Est. +$24.5M
Added
7
Est. +$3.82M
Reduced
5
Est. −$955.2K
Sold out
26
Est. −$19.9M

Top 5 holdings

Share of this quarter's portfolio value

  1. NXSTNexstar Media Group, Inc.
    6.2%$4.72MHistory
  2. CTXSCitrix Systems Inc
    6.2%$4.69MHistory
  3. AZOAutoZone Inc
    4.2%$3.19MHistory
  4. ROGRogers Corp
    4.1%$3.11MHistory
  5. ChemoCentryx, Inc.16383L106
    4.0%$3.00M

Share of portfolio

Top 5 holdings and the other 57 positions, by share of portfolio value

  1. NXST6.2%
  2. CTXS6.2%
  3. AZO4.2%
  4. ROG4.1%
  5. ChemoCentryx, Inc.4.0%
  6. Other 57 positions75.3%

Biggest buys

New and added positions, by estimated amount bought

  1. ChemoCentryx, Inc.16383L106
    +$3.00MNew
  2. GBTGlobal Blood Therapeutics, Inc.
    +$2.77MNewHistory
  3. RFPResolute Forest Products Inc.
    +$2.54MNewHistory
  4. NLSNNielsen Holdings plc
    +$2.49MNewHistory
  5. YAlleghany Corp
    +$2.43MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ChemoCentryx, Inc.16383L106
    +3.96 pp0.0% → 4.0%
  2. GBTGlobal Blood Therapeutics, Inc.
    +3.66 pp0.0% → 3.7%History
  3. RFPResolute Forest Products Inc.
    +3.35 pp0.0% → 3.4%History
  4. NLSNNielsen Holdings plc
    +3.28 pp0.0% → 3.3%History
  5. YAlleghany Corp
    +3.21 pp0.0% → 3.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. TPTXTurning Point Therapeutics, Inc.
    −$1.93MSold outHistory
  2. Atotech LtdG0625A105
    −$1.92MSold out
  3. Coherent Inc192479103
    −$1.62MSold out
  4. MTORMeritor, Inc.
    −$1.56MSold outHistory
  5. Sailpoint Technologies Holdings, Inc.78781P105
    −$1.32MSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TPTXTurning Point Therapeutics, Inc.
    −2.75 pp2.7% → 0.0%History
  2. Atotech LtdG0625A105
    −2.74 pp2.7% → 0.0%
  3. Coherent Inc192479103
    −2.32 pp2.3% → 0.0%
  4. MTORMeritor, Inc.
    −2.23 pp2.2% → 0.0%History
  5. Sailpoint Technologies Holdings, Inc.78781P105
    −1.88 pp1.9% → 0.0%

Metrics

13F metrics for Q3 2022, computed only from the numbers in the filings. Definitions below.

Portfolio value
$75.7M
+$5.58M (+8.0%) vs. prior quarter
Positions
62
−5 vs. prior quarter
Top 10 concentration
42.0%
Top 10 as share of value
Turnover
28.6%
Q3 2022, one quarter
Average holding period
3.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $118.6M (Q3 2021)

Q1 2021: $93.4MQ2 2021: $118.0MQ3 2021: $118.6MQ4 2021: $96.7MQ1 2022: $84.7MQ2 2022: $70.1MQ3 2022: $75.7M
Q1 2021Q3 2022
13F filings of S. Muoio & Co. LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2022Nov 14, 202262$75.7MNXSTCTXSAZOvs. Q2 2022SEC
Q2 2022Aug 15, 202267$70.1MNXSTCTXSAZOvs. Q1 2022SEC
Q1 2022May 13, 202282$84.7MNXSTAZOParamount Globalvs. Q4 2021SEC
Q4 2021Feb 10, 202282$96.7MNUANAZONXSTvs. Q3 2021SEC
Q3 2021Nov 15, 2021102$118.6MNXSTSTMPEQIXvs. Q2 2021SEC
Q2 2021Aug 16, 202198$118.0MPFPTWORKALXNvs. Q1 2021SEC
Q1 2021May 14, 202180$93.4MNXSTALXNEQIX–SEC